Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2022-11-16 00:00:00 ET · period of report 2022-11-14 · accession 0001127602-22-025761 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-16 | 2022-11-14 | BCRX | Babu Yarlagadda S | Chief Discovery Off | M - OptEx | $1.42 | +100.0K | 330.1K | +43% | +$142.0K |
| D | 2022-11-16 | 2022-11-14 | BCRX | Babu Yarlagadda S | Chief Discovery Off | S - Sale+OE | $13.88 | -31.5K | 298.5K | -10% | -$437.4K |
| DM | 2022-11-16 | 2022-11-14 | BCRX | Babu Yarlagadda S | Chief Discovery Off | M - OptEx | $0.00 | -100.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-14 | M | A | 50,000 | $1.42 | 280,056 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-14 | S | D | 31,515 | $13.88 | 298,541 | D | — | — | (F1) The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $13.86 to $13.92. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2022-11-14 | M | A | 50,000 | $1.42 | 330,056 | D | — | — | |
| 4 | Derivative | Emp. Stock Option (Right to Buy) | 2022-11-14 | M | D | 50,000 | $0.00 | 0 | D | $1.42 · 2014-01-01 to 2023-01-01 | 50,000 Common Stock | (F2) Annual Employee Option Grant became exercisable in four equal annual installments, beginning on this date. |
| 5 | Derivative | Emp. Stock Option (Right to Buy) | 2022-11-14 | M | D | 50,000 | $0.00 | 0 | D | $1.42 · 2014-01-01 to 2023-01-01 | 50,000 Common Stock | (F3) Retention Employee Stock Option became exercisable in two equal annual installments, beginning on this date. |